Deborah A. Bradley, MD, medical oncologist, Levine Cancer Institute, Atrium Health, discusses the importance of exercise in the management of prostate cancer treatment-related adverse events.
Deborah A. Bradley, MD, medical oncologist, Levine Cancer Institute, Atrium Health, discusses the importance of exercise in the management of prostate cancer treatment-related adverse events (AEs).
An area of prostate cancer that Bradley says needs more research is in terms of AE management for prostate cancer survivors. A lot of patients become very fatigued while undergoing therapy, and getting them up and exercising is an important way to overcome this. It is widely known that a common AE associated with chemotherapy is fatigue, but more work needs to be geared toward this. Bradley stressed that as therapy becomes more advanced, patient quality of life is a necessary important endpoint in clinical trials.
Additionally, as these therapies are moved into earlier settings, cardiac toxicity could become a factor. If a patient’s testosterone is being suppressed for such an extended period of time, researchers have to better understand the long-term AEs that could occur. Proper exercise regimens could be crucial here, as well.
As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority
Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD
Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma
Serial ctDNA Testing Could Improve Risk Stratification in High-Risk MIBC
2 Commerce Drive
Cranbury, NJ 08512